Table 2:

Basic haemodynamic and mechanic energy data of the studied groups of patients

Control (n = 20)ARNS (n = 41)ARS (n = 19)P-value
Mean ± SDMean ± SDMean ± SD
Age (years)57 ± 1558 ± 1557 ± 160.58
BMI (kg/m2)26.8 ± 5.625.6 ± 4.127.4 ± 4.80.55
HR (bpm)76 ± 1471 ± 1177 ± 150.18
Syst. BP (mmHg)137 ± 25140 ± 21135 ± 180.79
Diast. BP (mmHg)81 ± 1572 ± 972 ± 110.001
SW (mmHg × ml)7720 ± 235212 910 ± 564412 064 ± 59580.0001
Epot (mmHg × ml)3597 ± 10127118 ± 54016661 ± 35470.0001
PVA (mmHg × ml)11 254 ± 304519 950 ± 10 03118 593 ± 82810.001
EF (%)59 ± 659 ± 753 ± 110.01
Ees (mmHg/ml)2.54 ± 0.811.58 ± 0.691.45 ± 0.68<0.0001
GLS (%)−21.2 ± 2.4−15.7 ± 2.7−12.4 ± 3.4<0.0001
LVESDi (cm/m2)1.72 ± 0.32.04 ± 0.252.31 ± 0.42<0.0001
LV-mass (g)167 ± 44290 ± 87372 ± 168<0.0001
Control (n = 20)ARNS (n = 41)ARS (n = 19)P-value
Mean ± SDMean ± SDMean ± SD
Age (years)57 ± 1558 ± 1557 ± 160.58
BMI (kg/m2)26.8 ± 5.625.6 ± 4.127.4 ± 4.80.55
HR (bpm)76 ± 1471 ± 1177 ± 150.18
Syst. BP (mmHg)137 ± 25140 ± 21135 ± 180.79
Diast. BP (mmHg)81 ± 1572 ± 972 ± 110.001
SW (mmHg × ml)7720 ± 235212 910 ± 564412 064 ± 59580.0001
Epot (mmHg × ml)3597 ± 10127118 ± 54016661 ± 35470.0001
PVA (mmHg × ml)11 254 ± 304519 950 ± 10 03118 593 ± 82810.001
EF (%)59 ± 659 ± 753 ± 110.01
Ees (mmHg/ml)2.54 ± 0.811.58 ± 0.691.45 ± 0.68<0.0001
GLS (%)−21.2 ± 2.4−15.7 ± 2.7−12.4 ± 3.4<0.0001
LVESDi (cm/m2)1.72 ± 0.32.04 ± 0.252.31 ± 0.42<0.0001
LV-mass (g)167 ± 44290 ± 87372 ± 168<0.0001

P-values describe the result of the one-way ANOVA test.

BMI: body mass index; BP: blood pressure; Ees: end-systolic elastance; EF: ejection fraction; GLS: global longitudinal strain; HR: heart rate; LVESD: left ventricular end-systolic diameter; PVA: pressure–volume area; SD: standard deviation; SW: stroke work.

Table 2:

Basic haemodynamic and mechanic energy data of the studied groups of patients

Control (n = 20)ARNS (n = 41)ARS (n = 19)P-value
Mean ± SDMean ± SDMean ± SD
Age (years)57 ± 1558 ± 1557 ± 160.58
BMI (kg/m2)26.8 ± 5.625.6 ± 4.127.4 ± 4.80.55
HR (bpm)76 ± 1471 ± 1177 ± 150.18
Syst. BP (mmHg)137 ± 25140 ± 21135 ± 180.79
Diast. BP (mmHg)81 ± 1572 ± 972 ± 110.001
SW (mmHg × ml)7720 ± 235212 910 ± 564412 064 ± 59580.0001
Epot (mmHg × ml)3597 ± 10127118 ± 54016661 ± 35470.0001
PVA (mmHg × ml)11 254 ± 304519 950 ± 10 03118 593 ± 82810.001
EF (%)59 ± 659 ± 753 ± 110.01
Ees (mmHg/ml)2.54 ± 0.811.58 ± 0.691.45 ± 0.68<0.0001
GLS (%)−21.2 ± 2.4−15.7 ± 2.7−12.4 ± 3.4<0.0001
LVESDi (cm/m2)1.72 ± 0.32.04 ± 0.252.31 ± 0.42<0.0001
LV-mass (g)167 ± 44290 ± 87372 ± 168<0.0001
Control (n = 20)ARNS (n = 41)ARS (n = 19)P-value
Mean ± SDMean ± SDMean ± SD
Age (years)57 ± 1558 ± 1557 ± 160.58
BMI (kg/m2)26.8 ± 5.625.6 ± 4.127.4 ± 4.80.55
HR (bpm)76 ± 1471 ± 1177 ± 150.18
Syst. BP (mmHg)137 ± 25140 ± 21135 ± 180.79
Diast. BP (mmHg)81 ± 1572 ± 972 ± 110.001
SW (mmHg × ml)7720 ± 235212 910 ± 564412 064 ± 59580.0001
Epot (mmHg × ml)3597 ± 10127118 ± 54016661 ± 35470.0001
PVA (mmHg × ml)11 254 ± 304519 950 ± 10 03118 593 ± 82810.001
EF (%)59 ± 659 ± 753 ± 110.01
Ees (mmHg/ml)2.54 ± 0.811.58 ± 0.691.45 ± 0.68<0.0001
GLS (%)−21.2 ± 2.4−15.7 ± 2.7−12.4 ± 3.4<0.0001
LVESDi (cm/m2)1.72 ± 0.32.04 ± 0.252.31 ± 0.42<0.0001
LV-mass (g)167 ± 44290 ± 87372 ± 168<0.0001

P-values describe the result of the one-way ANOVA test.

BMI: body mass index; BP: blood pressure; Ees: end-systolic elastance; EF: ejection fraction; GLS: global longitudinal strain; HR: heart rate; LVESD: left ventricular end-systolic diameter; PVA: pressure–volume area; SD: standard deviation; SW: stroke work.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close